Followers | 10 |
Posts | 1467 |
Boards Moderated | 0 |
Alias Born | 07/16/2006 |
Saturday, November 22, 2014 6:38:31 PM
_____________________________________________________________
increasingly disgruntled investors the board just isn't fun to read anymore
_______________________________________________________________
It seems to me there are two camps using this board.
One camp usually/always presents a negative point of view and keeps looking in a distant rear view mirror. This camp has 6 at most posters, some of who are suspected of using multiple alias.
This camp is what makes the board hard to read as there are so many rebuttals that distract from the facts.
The other camp is way bigger and have many more forward looking positive points of view.
For example:
6,000+ tested animals with only positive, for NNV,C results.
A new Plant being certified NOW. Built in the last year. A state of the art facility. Expected to be open in 1/2015. Capacity to greatly increase from 200gs per batch in the Wood street lab.
Lab reports ( all labs are independent of NNVC) that show Flucide is 1,500x more effective than Tamiflu. All subject animals survived with Flucide (sacrificed after 28 days and not toxicity found)vs dead after 8 days(Tamiflu) or 5days untreated. BASi now doing toxicity testing with "NO BAD NEWS" REPORTED TO DATE! This daily non reporting translates to good news.
See post from changes_iv for a better list of a programs underway.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM